‘Navel-gazing’ Aviva could be left behind
The first interim results from insurer Aviva (AV) following the acquisition of Friends Life is a mixed bag.
Shore Capital analyst Eamonn Flanagan retained his ‘sell at 527p’ recommendation on the shares, which rose 1.4% to 534.9p yesterday.